Home/Filings/4/0001144204-13-065120
4//SEC Filing

Targeted Medical Pharma, Inc. 4

Accession 0001144204-13-065120

CIK 0001420030operating

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 5:47 PM ET

Size

14.8 KB

Accession

0001144204-13-065120

Insider Transaction Report

Form 4
Period: 2013-12-02
Shell William
DirectorCEO/Chief Scientific Officer10% Owner
Transactions
  • Other

    Common Stock, $.001 par value per share

    2013-12-02+177,7255,530,102 total(indirect: By Trust)
  • Other

    Common Stock, $.001 par value per share

    2013-12-02+236,9676,300,245 total(indirect: By Trust)
  • Other

    Common Stock, $.001 par value per share

    2013-12-02+296,2096,063,278 total(indirect: By Trust)
  • Other

    Common Stock, $.001 par value per share

    2013-12-02+236,9675,352,377 total(indirect: By Trust)
  • Other

    Common Stock, $.001 par value per share

    2013-12-02+236,9675,767,069 total(indirect: By Trust)
Transactions
  • Other

    Common Stock, $.001 par value per share

    2013-12-02+177,7255,530,102 total(indirect: By Trust)
  • Other

    Common Stock, $.001 par value per share

    2013-12-02+296,2096,063,278 total(indirect: By Trust)
  • Other

    Common Stock, $.001 par value per share

    2013-12-02+236,9675,767,069 total(indirect: By Trust)
  • Other

    Common Stock, $.001 par value per share

    2013-12-02+236,9675,352,377 total(indirect: By Trust)
  • Other

    Common Stock, $.001 par value per share

    2013-12-02+236,9676,300,245 total(indirect: By Trust)
Footnotes (6)
  • [F1]On December 2, 2013, William Shell Survivor's Trust was issued 236,967 shares of common stock of Targeted Medical Pharma, Inc. (the "Common Stock") as repayment for a $200,000 note payable dated January 31, 2012 issued by the Company in favor of the Reporting Person. The Common Stock was issued at a price of $0.844 per share.
  • [F2]Common stock is held by Willliam Shell Survivor's Trust.
  • [F3]On December 2, 2013, William Shell Survivor's Trust was issued 296,209 shares of Common Stock as repayment for a $250,000 note payable dated February 1, 2012 issued by the Company in favor of the Reporting Person. The Common Stock was issued at a price of $0.844 per share.
  • [F4]On December 2, 2013, William Shell Survivor's Trust was issued 236,967 shares of Common Stock as repayment for a $200,000 note payable dated February 15, 2012 issued by the Company in favor of the Reporting Person. The Common Stock was issued at a price of $0.844 per share.
  • [F5]On December 2, 2013, William Shell Survivor's Trust was issued 177,725 shares of Common Stock as repayment for a $150,000 note payable dated March 28, 2012 issued by the Company in favor of the Reporting Person. The Common Stock was issued at a price of $0.844 per share.
  • [F6]On December 2, 2013, William Shell Survivor's Trust was issued 236,967 shares of Common Stock as repayment for a $200,000 note payable dated April 26, 2012 issued by the Company in favor of the Reporting Person. The Common Stock was issued at a price of $0.844 per share.

Issuer

Targeted Medical Pharma, Inc.

CIK 0001420030

Entity typeoperating

Related Parties

1
  • filerCIK 0001420030

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 5:47 PM ET
Size
14.8 KB